Session Information
Session Type: ACR Concurrent Abstract Session
Session Time: 4:30PM-6:00PM
Background/Purpose: Gout, caused by hyperuricaemia, is a multifactorial disease. Recently, genome-wide association studies (GWASs) of gout have been reported; however, they included self-reported gout cases. Therefore, the relationship between genetic variation and clinical subtypes of gout remains to be clarified. We hereby first performed a GWAS of clinically-defined gout cases only.
Methods: A GWAS was conducted with 945 clinically-defined gout cases and 1,213 controls in a Japanese male population. Additionally, a replication study of 1,048 clinically-defined cases and 1,334 controls was performed.
Results: We identified five susceptibility loci for gout at the genome-wide significance level (p≺ 5.0 × 10-8, which contained well-known urate transporter genes (ABCG2 and SLC2A9) and additional genes reported to have relationships with metabolic pathways: rs1260326 (p = 1.9 × 10-12; OR = 1.36) of GCKR (a gene for glucose and lipid metabolism), rs2188380 (p = 1.6 × 10-23; OR = 1.75) of MYL2-CUX2 (genes associated with cholesterol and diabetes mellitus), and rs4073582 (p = 6.4 × 10-9; OR = 1.66) of CNIH-2 (a gene for regulation of glutamate signaling). The latter two are identified as novel loci for gout. Furthermore, we demonstrated that the identified SNPs were differentially associated with types of gout and clinical parameters underlying specific subtypes. The effect of the risk allele of each SNP on clinical parameters showed significant linear relationships with the ratio of the case-control ORs for two distinct types of gout (r = 0.96 [p = 4.8 × 10-4] for urate clearance and r = 0.96 [p = 5.0 × 10-4] for urinary urate excretion).
Conclusion: Our findings provide clues to better understand the pathogenesis of gout and will be useful to develop companion diagnostics of gout.
To cite this abstract in AMA style:
Matsuo H, Yamamoto K, Nakaoka H, Nakayama A, Sakiyama M, Takahashi A, Nakamura T, Kawamura Y, Hamajima N, Inoue I, Kubo M, Ichida K, Ooyama H, Shimizu T, Shinomiya N. Genome-Wide Association Study of Clinically-Defined Gout Identifies Multiple Risk Loci: A Clue for Future Companion Diagnostics of Gout [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/genome-wide-association-study-of-clinically-defined-gout-identifies-multiple-risk-loci-a-clue-for-future-companion-diagnostics-of-gout/. Accessed .« Back to 2015 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/genome-wide-association-study-of-clinically-defined-gout-identifies-multiple-risk-loci-a-clue-for-future-companion-diagnostics-of-gout/